140 related articles for article (PubMed ID: 9786263)
1. Tissue inhibitor of metalloproteinase-1 is increased in the saphenofemoral junction of patients with varices in the leg.
Parra JR; Cambria RA; Hower CD; Dassow MS; Freischlag JA; Seabrook GR; Towne JB
J Vasc Surg; 1998 Oct; 28(4):669-75. PubMed ID: 9786263
[TBL] [Abstract][Full Text] [Related]
2. Disequilibrium in MMPs and the tissue inhibitor of metalloproteinases in different segments of the varicose great saphenous vein wall.
Hu X; Hu F; Xu Y; Tang J; Chu H; Zhong Y
Int Angiol; 2019 Jun; 38(3):185-193. PubMed ID: 31058480
[TBL] [Abstract][Full Text] [Related]
3. Morphologic characteristics of varicose veins: possible role of metalloproteinases.
Woodside KJ; Hu M; Burke A; Murakami M; Pounds LL; Killewich LA; Daller JA; Hunter GC
J Vasc Surg; 2003 Jul; 38(1):162-9. PubMed ID: 12844106
[TBL] [Abstract][Full Text] [Related]
4. Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13.
Gillespie DL; Patel A; Fileta B; Chang A; Barnes S; Flagg A; Kidwell M; Villavicencio JL; Rich NM
J Surg Res; 2002 Aug; 106(2):233-8. PubMed ID: 12175972
[TBL] [Abstract][Full Text] [Related]
5. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
6. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis.
Porter KE; Thompson MM; Loftus IM; McDermott E; Jones L; Crowther M; Bell PR; London NJ
Eur J Vasc Endovasc Surg; 1999 May; 17(5):404-12. PubMed ID: 10329524
[TBL] [Abstract][Full Text] [Related]
7. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs.
Tatsuguchi A; Fukuda Y; Ishizaki M; Yamanaka N
Digestion; 1999; 60(3):246-54. PubMed ID: 10343138
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
[TBL] [Abstract][Full Text] [Related]
9. Metalloproteinase expression in venous aneurysms.
Irwin C; Synn A; Kraiss L; Zhang Q; Griffen MM; Hunter GC
J Vasc Surg; 2008 Nov; 48(5):1278-85. PubMed ID: 18971037
[TBL] [Abstract][Full Text] [Related]
10. Clinico-histopathological study of varicose vein and role of matrix metalloproteinases-1, matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinase-1 in varicose vein formation.
Naik B; Kumar M; Khanna AK; Suman PK
Indian J Pathol Microbiol; 2016; 59(1):25-30. PubMed ID: 26960630
[TBL] [Abstract][Full Text] [Related]
11. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein.
George SJ; Zaltsman AB; Newby AC
Cardiovasc Res; 1997 Feb; 33(2):447-59. PubMed ID: 9074710
[TBL] [Abstract][Full Text] [Related]
12. Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis.
Gomez DE; De Lorenzo MS; Alonso DF; Andrade ZA
Am J Trop Med Hyg; 1999 Jul; 61(1):9-13. PubMed ID: 10432047
[TBL] [Abstract][Full Text] [Related]
13. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
[TBL] [Abstract][Full Text] [Related]
14. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
[TBL] [Abstract][Full Text] [Related]
15. Shear force regulates matrix metalloproteinase activity in human saphenous vein organ culture.
Patterson MA; Leville CD; Hower CD; Jean-Claude JM; Seabrook GR; Towne JB; Cambria RA
J Surg Res; 2001 Jan; 95(1):67-72. PubMed ID: 11120638
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases in the vein wall.
Kowalewski R; Sobolewski K; Wolanska M; Gacko M
Int Angiol; 2004 Jun; 23(2):164-9. PubMed ID: 15507895
[TBL] [Abstract][Full Text] [Related]
17. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).
Hayashi T; Fleming MV; Stetler-Stevenson WG; Liotta LA; Moss J; Ferrans VJ; Travis WD
Hum Pathol; 1997 Sep; 28(9):1071-8. PubMed ID: 9308732
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
